Sarepta Therapeutics | Driftskostnader

Operating Expenses Endring Dato
Acadia Pharmaceuticals USD 190.62M 5.48M 2024-03
Agios Pharmaceuticals USD 100.26M 13.12M 2024-03
Alnylam Pharmaceuticals USD 537.77M 18.35M 2024-03
Amgen USD 6.46B 469M 2024-03
Avrobio USD 7.94M 782K 2024-03
Biogen USD 1.72B 306.9M 2024-03
BioMarin Pharmaceutical USD 570.37M 61.62M 2024-03
Daiichi Sankyo JPY 347.44B 22.96B 2023-12
Eli Lilly USD 6.03B 933.2M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03
Incyte USD 789.54M 36.54M 2024-03
Insmed USD 232.9M 29.06M 2024-03
Ionis Pharmaceuticals USD 269.01M 34.82M 2024-03
Moderna USD 1.43B 1.37B 2024-03
Neurocrine Biosciences USD 410M 52.4M 2024-03
Pfizer USD 10.68B 10.12B 2024-03
PTC Therapeutics USD 255.67M 183.12M 2024-03
Regeneron Pharmaceuticals USD 2.39B 74.9M 2024-03
Roche Holding CHF 20.02B 5.04B 2023-06
Sanofi EUR 8.89B 600M 2024-03
Sarepta Therapeutics USD 378.56M 1.6M 2024-03
Ultragenyx Pharmaceutical USD 274.18M 24.74M 2024-03
Vertex Pharmaceuticals USD 1.47B 29M 2024-03



Sarepta Therapeutics Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.